Key facts
- Boots is reportedly in discussions for a potential $10 billion sale.
- The company's owners are considering abandoning an initial public offering.
- Potential bidders include the Weston family and Sigma Healthcare.
Boots is reportedly engaged in discussions concerning a potential sale valued at approximately $10 billion. This development suggests a strategic pivot away from pursuing an initial public offering as the preferred route for its future ownership structure and market engagement. Bidders for the pharmacy and health retailer include the Weston family and Australian pharmacy group Sigma Healthcare.